Test
| # | Name | Method | Specification | Specimen Vol. | Temp. | Report |
|---|---|---|---|---|---|---|
| 1 | 1.25 -HDROXY/Cholecalciferol (VITAMIN D-3) | ELISA | SERUM/PLASMA-EDTA (Specimen to be protected from light.Warp tube in aluminium foil) FASTING 12-14 HRS CLINICAL HISTORY | 2.0 ML | F | SAME DAY |
| 2 | 21 HYDROXYLASE ANTIBODY | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 3 | 17 KETO STEROID-SERUM | RIA | SERUM | 2.0 ML | F | NEXT DAY |
| 4 | 17-OH PROGESTRONE | RIA | SERUM(AGE & SEX REQUIRED) | 2.0 ML | F | NEXT DAY |
| 5 | 25- DIHYDROXY,Ergocalciferol (VITAMIN D) | ELISA | SERUM/PLASMA-EDTA(Specimen to be protected from light.Warp tube in aluminium foil) FASTING 12-14 HRS CLINICAL HISTORY | 2.0 ML | F | SAME DAY |
| 6 | 5-HIAA-SERUM (5-HYDROXYINDOLEACETIC ACID) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 7 | 5-HIAA-URINE (5-HYDROXYINDOLEACETIC ACID) | ELISA | URINE 24 HRS (Collected in 10ml conc HCL:Mention 24hrs. Total volume TRF)DO NOT CONSUME BANANAS ,PINEAPPLE,NUTS 48HRS PRIOR TO THE COLLECTION OF THE SPECIMEN MENTION CLINICAL DETAILS OF THE PATIENT ON THE REQ FORM | 10.0 ML | F | NEXT DAY |
| 8 | ABSOLUTE LYMPHOCYTE COUNT | CELL COUNTER | WB-EDTA | 2.0 ML | A | SAME DAY |
| 9 | ABSOLUTE NEUTROPHILS COUNT | CELL COUNTER | WB-EDTA | 2.0 ML | A | SAME DAY |
| 10 | ABSOLUTE RETICULOCYTE COUNT | CELL COUNTER | WB-EDTA | 2.0 ML | A | SAME DAY |
| 11 | ACE-CSF ANGIOTENSIN CONVERTING ENZYM | BIOCHEMISTRY | CSF | 2.0 ML | R/F | SAME DAY |
| 12 | ACE-SERUM ANGIOTENSIN CONVERTING ENZYM | BIOCHEMISTRY | SERUM | 2.0 ML | R/F | SAME DAY |
| 13 | ACETONE,SERUM | BIOCHEMISTRY | SERUM | 2.0 ML | R/F | SAME DAY |
| 14 | ACID PHOSPHATASE (PROSTATIC FRACTION) | BIOCHEMISTRY | SERUM | 2.0 ML | F | NEXT DAY |
| 15 | ADENOSINE DEAMINASE (ADA) | BIOCHEMISTRY | SERUM | 2.0 ML | F | SAME DAY |
| 16 | ADENOSINE DEAMINASE (ADA) | BIOCHEMISTRY | PLEURAL FLUID/PUS/CSF | 2.0 ML | F | SAME DAY |
| 17 | ADENOVIRUS-IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 18 | ADENOVIRUS-IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 19 | ADH-ANTI DIURETIC HORMON (VASOPRESSIN) | ELISA | SERUM/PLASMA-EDTA | 2.0 ML | F | SAME DAY |
| 20 | ADRENOCORTCOTROPIC HARMONE-(ACTH) | RIA | EDTA PLASMA(Freeze the specimen immeditaly after sepration.specimen collected between 6- 10am is desirable )+CLINICAL HISTORY | 2.0 ML | F | SAME DAY |
| 21 | ALANINE AMINO TRANSFERASE (SGPT/ALT) | BIOCHEMISTRY | SERUM | 2.0 ML | R/F | SAME DAY |
| 22 | ALBUMINE | BIOCHEMISTRY | SERUM | 2.0 ML | R/F | SAME DAY |
| 23 | ALBUMINE/GLOBULINE-RATIO | BIOCHEMISTRY | SERUM | 2.0 ML | R/F | SAME DAY |
| 24 | ALDOLASE | RIA | SERUM | 2.0 ML | F | NEXT DAY |
| 25 | ALDOSTERONE-SERUM | RIA | SERUM(Age & Sex,clinical treatment history required if patient is on spirolactone or ACE inhibitors) | 2.0 ML | F | NEXT DAY |
| 26 | ALDOSTERONE-URINE | RIA | URINE(Age & Sex,clinical treatment history required if patient is on spirolactone or ACE inhibitors) | 10.0 ML | F | NEXT DAY |
| 27 | ALKALINE PHOSPHATASE | BIOCHEMISTRY | SERUM | 2.0 ML | R/F | SAME DAY |
| 28 | ALOCOHOL (ETHANOL),SERUM | BIOCHEMISTRY | SERUM | 2.0 ML | R/F | NEXT DAY |
| 29 | ALPHA FETO PROTINE -(AFP) | CHEMILUMINESCE | SERUM(AGE+SEX+CLINICALHISTORY) | 2.0 ML | R/F | SAME DAY |
| 30 | ALPHA FETO PROTINE -(AFP) | CHEMILUMINESCE | AMNIOTIC FLUID (AGE+SEX+CLINICALHISTORY) | 2.0 ML | R/F | SAME DAY |
| 31 | ALPHA-1-ANTITRYPSIN | NEPHELOMETRY | SERUM | 2.0 ML | R/F | NEXT DAY |
| 32 | ALUMINIUM,24 HRS URINE | SPECTROMETRY | 24 HR URINE (Preservative:15 gm Boric Acid) 24 HRS URINE VOLUME | 10.0ML | R | NEXT DAY |
| 33 | ALUMINIUM,BLOOD | SPECTROMETRY | EDTA WHOLE BLOOD(Should reach ENDO.Lab.within 24 hrs of collection) | 2.0 ML | R | NEXT DAY |
| 34 | ALUMINIUM,URINE SPOT | SPECTROMETRY | URINE,SPOT | 10.0ML | R | NEXT DAY |
| 35 | ANTI MITOCHONDRIAL ANTI BODY -AMA | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 36 | ELISA SERUM 2.0 ML F NEXT DAY | |||||
| 37 | AMINO ACID,PLASMA | BIOCHEMISTRY | PLASMA HEPARIN+CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 38 | AMPHETAMINE | ELISA | SERUM/URINE-(CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 39 | AMYLASE | BIOCHEMISTRY | SERUM | 2.0 ML | F | SAME DAY |
| 40 | ANA | ELISA | SERUM | 2.0 ML | R/F | SAME DAY |
| 41 | ANA /ANF(IMMUNOFLOURESCENT) | IMMUNOFLOURESCENT | SERUM | 2.0 ML | R/F | SAME DAY |
| 42 | ANA- PROFILE | ELISA | SERUM | 2.0 ML | R/F | SAME DAY |
| 43 | ANCA -C | ELISA | SERUM | 2.0 ML | R/F | SAME DAY |
| 44 | ANCA -P | ELISA | SERUM | 2.0 ML | R/F | SAME DAY |
| 45 | ANDROGEN (FSH,LH,TESTOSTERONE,FREE TSETOSTERON) | CHEMILUMINESCE | SERUM(AGE+SEX+CLINICALHISTORY)SEMPLE TO BE DRAW IN THE MORNING HOURS | 2.0 ML | F | SAME DAY |
| 46 | ANDROSTENEDIONE | RIA | SERUM | 2.0 ML | A/R/F | NEXT DAY |
| 47 | ANTI AMOEBIASIS Ab-IgG ( E.HISTOLYTICA ) | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 48 | ANTI AMOEBIASIS Ab-IgM ( E.HISTOLYTICA ) | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 49 | ANTI CARDIOLIPIN ANTIBODY-IgA | Elisa | SERUM | 2.0 ML | R/F | SAME DAY |
| 50 | ANTI CARDIOLIPIN ANTIBODY-IgG | ELISA | SERUM | 2.0 ML | R/F | SAME DAY |
| 51 | ANTI CARDIOLIPIN ANTIBODY-IgM | ELISA | SERUM | 2.0 ML | R/F | SAME DAY |
| 52 | ANTI CCP ANTIBODIES | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 53 | ANTI D TITER ANTIBODY TITER | CHEMILUMINESCE | SERUM | 2.0 ML | R/F | SAME DAY |
| 54 | ANTI DELTA VIRUS ANTIBODY (Total) | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 55 | ANTI DS DNA | ELISA | SERUM | 2.0 ML | R/F | SAME DAY |
| 56 | ANTI GLIADIN Ab- IgA | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 57 | ANTI GLIADIN Ab- IgG | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 58 | ANTI MICROSOMAL ANTIBODY.-(AMA)/TPO | CHEMILUMINESCE | SERUM | 2.0 ML | F | SAME DAY |
| 59 | ANTI MYOCARDIAL ANTI BODY | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 60 | ANTI NMO ANTIBODY | SERUM/CSF | 2.0 ML | 03 DAYS | ||
| 61 | ANTI OVARIAN ANTIBODY (AOA) | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 62 | ANTI PARIETAL CELL ANTIBODY | IMMUNO FLUORESENT ASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 63 | ANTI PHOSHO LIPIDS ANTIBODY-IgA | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 64 | ANTI PHOSHO LIPIDS ANTIBODY-IgG | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 65 | ANTI PHOSHO LIPIDS ANTIBODY-IgM | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 66 | ANTI POLIO – IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 67 | ANTI POLIO – IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 68 | ANTI SACCHAROMYCES CERVISIAE (ASCA) -IgA | IMMUNO FLUORESENT ASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 69 | ANTI SACCHAROMYCES CERVISIAE (ASCA) -IgG | IMMUNO FLUORESENT ASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 70 | ANTI SMOOTH MUSCLE AB-(ASMA) | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 71 | ANTI SPERM ANTIBODY -IgG-(ASA) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 72 | ANTI SPERM ANTIBODY -IgM-(ASA) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 73 | ANTI STREPTOLYSIN-O- ANTIBODY (ASO) | NEPHELOMETRY | SERUM(AGE+SEX+CLINICALHISTORY) Sample to be drawn in the morning hours | 2.0 ML | F | SAME DAY |
| 74 | ANTI THROMBIN III | COAGULATION | Fasting,CITRATED PLATELET POOR PLASMA- AT MINUS 20 C+ CLINICAL HISTORY,(DOUBLE CENTRIFUGED PLASMA) | 2.0 ML | F | NEXT DAY |
| 75 | ANTIBODY TO RNA ?Sm | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 76 | ANTIBODY TO SCL ? 70 | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 77 | ANTIBODY TO Sm Ag | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 78 | ANTIBODY TO SSa (Ro) | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 79 | ANTIBODY TO SSB (La) | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 80 | ANTIBODY TO UI-SN-RNP -(68Kda) | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 81 | APOLIPO -A1 | NEPHELOMETRY | 12-14 HRS FASTING SERUM(AGE+SEX+CLINICALHISTORY) | 2.0 ML | F | NEXT DAY |
| 82 | APOLIPO -B | NEPHELOMETRY | 12-14 HRS FASTING SERUM(AGE+SEX+CLINICALHISTORY) | 2.0 ML | F | NEXT DAY |
| 83 | APOLIPOPROTINE EVALUTION Apolipo A1/B,Lp(a) | NEPHELOMETRY | 12-14 HRS FASTING SERUM(AGE+SEX+CLINICALHISTORY | 2.0 ML | F | NEXT DAY |
| 84 | APTT (ACTIVATATIVE PTT) | COAGULATION | Fasting,CITRATED PLATELET POOR PLASMA- AT MINUS 20 C + CLINICAL HISTORY,(DOUBLE CENTRIFUGED PLASMA) | 2.0 ML | F | SAME DAY |
| 85 | ARSENIC,24 HR URINE | ATOMIC ABSORPTION SPECTROMETRY | 24 HR URINE(NO PRESERVATIVE,IN DARK CONTANER) MENTION 24 HRS VOLUM | 10.0 ML | F | NEXT DAY |
| 86 | ARSENIC,BLOOD | ATOMIC ABSORPTION SPECTROMETRY | EDTA WHOLE BLOOD | 2.0 ML | F | NEXT DAY |
| 87 | ARSENIC,URINE SPOT | ATOMIC ABSORPTION SPECTROMETRY | URINE SPOT(IN DARK LEAKPROOFCONTANER) | 10.0 ML | F | NEXT DAY |
| 88 | ASCARIS -IgG | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 89 | ASCARIS -IgM | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 90 | ASPATATE AMINO TRANSFERASE (SGPT/ALT) | BIOCHEMISTRY | SERUM | 2.0 ML | R/F | SAME DAY |
| 91 | ASPEROGILLUS – IgA | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 92 | ASPEROGILLUS – IgE | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 93 | ASPEROGILLUS – IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 94 | ASPEROGILLUS – IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 95 | B.TYPE NATRIURETIC PEPTIDE ( BNP) | CHEMILUMINESCE | WB-EDTA+HEPARIN | 2.0 ML | F | SAME DAY |
| 96 | B.TYPE NATRIURETIC PEPTIDE (PRO-BNP) | CHEMILUMINESCE | WB-EDTA+HEPARIN | 2.0 ML | A/R | NEXT DAY |
| 97 | BARBITURATES-SERUM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 98 | BARBITURATES-URINE | ELISA | URINE- (CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 99 | BENCE JONES PROTEIN | BIOCHEMISTRY | URINE | 10.0 ML | F | SAME DAY |
| 100 | BENZODIAZEPINE | ELISA | SERUM/URINE-(CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 101 | BENZODIAZEPINE | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 102 | BETA HCG | CHEMILUMINESCE | SERUM(AGE+SEX+ CLINICAL HISTORY) | 1.0 ML | F | SAME DAY |
| 103 | BETA HCG (FREE) | CHEMILUMINESCE | URINE(AGE+SEX+CLINICAL HISTORY) | 10.0 ML | F | SAME DAY |
| 104 | BETA-2 GLYCOPROTEIN IgG | ELISA | SERUM(CLINICAL HISTORY REQUIRED) | 2.0 ML | F | NEXT DAY |
| 105 | BETA-2 GLYCOPROTEIN IgM | ELISA | SERUM (CLINICAL HISTORY REQUIRED) | 2.0 ML | F | NEXT DAY |
| 106 | BETA-2 MICROGLOBULIN-SERUM | CHEMILUMINESCE | SERUM (CLINICAL HISTORY REQUIRED) | 2.0 ML | F | NEXT DAY |
| 107 | BETA-2 MICROGLOBULIN-URINE | CHEMILUMINESCE | URINE (CLINICAL HISTORY REQUIRED) | 10.0 ML | F | NEXT DAY |
| 108 | BETA-2 TRANSFERRIN ESTIMATION | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 109 | BICARBONATE | BIOCHEMISTRY | SERUM | 2.0 ML | F | SAME DAY |
| 110 | BILIRUBIN (TOTAL+DIRECT+INDIRECT) | BIOCHEMISTRY | SERUM | 2.0 ML | F | NEXT DAY |
| 111 | BLOOD UREA NITROGEN(BUN) | BIOCHEMISTRY | SERUM | 2.0 ML | F | SAME DAY |
| 112 | BROMINE LEVEL | BIOCHEMISTRY | SERUM | 2.0 ML | F | NEXT DAY |
| 113 | BRUCELLA- IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 114 | BRUCELLA- IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 115 | ||||||
| 116 | ||||||
| 117 | C PEPTIDE (PRO- INSULINE) | CHEMILUMINESCE | FASTING SERUM | 2.0 ML | F | SAME DAY |
| 118 | C PEPTIDE -URINE | CHEMILUMINESCE | FASTING URINE | 2.0 ML | F | SAME DAY |
| 119 | C 3 | NEPHELOMETRY | SERUM(AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 120 | C 4 | NEPHELOMETRY | SERUM(AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 121 | C1 ESTERASE | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 122 | C1Q | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 123 | CA – 72.4 (GASTRIC CANCER) | CHEMILUMINESCE | SERUM -(CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 124 | CA -125 (OVARIAN CANCER) | CHEMILUMINESCE | SERUM -(CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 125 | CA -15.3 (BREST CANCER ) | CHEMILUMINESCE | SERUM -(CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 126 | CA -19.9 (PANCREATIC OR STOMACH) | CHEMILUMINESCE | SERUM -(CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 127 | CADMIUM | AAS | WB-Na.Heparin | 2.0 ML | F | NEXT DAY |
| 128 | CALCITONINE LEVEL | RIA | SERUM -(CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 129 | CALCITONINE -PRO | RIA | SERUM -(CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 130 | CALCIUM -IONZED | ELECTROLYTE | SERUM | 2.0 ML | F | SAME DAY |
| 131 | CALCIUM -URINE | ELECTROLYTE | SERUM | 2.0 ML | F | SAME DAY |
| 132 | CANDIDA IgG | IMMUNOCAP | SERUM | 2.0 ML | F | NEXT DAY |
| 133 | CANDIDA IgM | IMMUNOCAP | SERUM | 2.0 ML | F | NEXT DAY |
| 134 | CANNABIS (MARIJUANA) | ELISA | SERUM/URINE-(CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 135 | CARBEZAPAINE (TEGRETOL) | CHEMILUMINESCE | SERUM(Treatment history required) For therepetic level sample should be collected just before oral dose.For toxic levels collection should be 4-8 hours post dose | 2.0 ML | F | NEXT DAY |
| 136 | CASONIC ANTIBODY -IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 137 | CASONIC ANTIBODY – IgM | ELISA | SERUM | 2.0 ML | A | NEXT DAY |
| 138 | CATECHOLAMINE- 24 HRS URINE- (METANEPINEPHRINE NOR METANEPINEPHRINE CATECHOLAMINE) | ELISA | URINE (Sample to be strictly collected in 15ml of 6N HCL)) | 20.0 ML | F | NEXT DAY |
| 139 | CATECHOLAMINE -PLASMA (METANEPINEPHRINENOR METANEPINEPHRINE CATECHOLAMINE) | ELISA | SERUM/PLASMA EDTA.CLINICAL HISTORY MANDATORY | 2.0 ML | F | NEXT DAY |
| 140 | CBC | CELL COUNTER | WB-EDTA | 2.0 ML | A | SAME DAY |
| 141 | CD4,CD8 | FLOCYTOMETRY | WB-EDTA | 2.0 ML | A | SAME DAY |
| 142 | CEA-CARCINO EMBRYONIC ANTIGEN | CHEMILUMINESCE | SERUM(CLINICAL HISTORY)) | 2.0 ML | F | SAME DAY |
| 143 | CENTROMERA ANTIBODY | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 144 | CERRULOPLASMIN | NEPHELOMETRY | SERUM(Age& Sex of the patient is man datory for reporting) | 2.0 ML | F | SAME DAY |
| 145 | CERULOPLASMIN-URINE | NEPHELOMETRY | URINE(Age& Sex of the patient is man datory for reporting) | 10.0 ML | F | SAME DAY |
| 146 | CHICKEN POX – Ig (VARICELLA ZOSTER VIRUS) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 147 | CHIKUN GUNYA -G | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 148 | CHIKUN GUNYA -M | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 149 | CHLAMYDIA TRACHOMATIS- IgA | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 150 | CHLAMYDIA TRACHOMATIS- IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 151 | CHLAMYDIA TRACHOMATIS- IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 152 | CHLOROQUINE LEVEL | CHEMILUMINESCE | SERUM | 2.0 ML | A | NEXT DAY |
| 153 | CHOLESTROL TRIGLYCERIDES-TG | BIOCHEMISTRY | FASTING SERUM | 2.0 ML | F | SAME DAY |
| 154 | CHOLESTROL-HDL | BIOCHEMISTRY | FASTING SERUM | 2.0 ML | F | SAME DAY |
| 155 | CHOLESTROL-LDL | BIOCHEMISTRY | FASTING SERUM | 2.0 ML | F | SAME DAY |
| 156 | CHOLESTROL-TOTAL | BIOCHEMISTRY | FASTING SERUM | 2.0 ML | F | SAME DAY |
| 157 | CHOLIN ESTERASE | BIOCHEMISTRY | SERUM | 2.0 ML | A | NEXT DAY |
| 158 | CHROMIUM | ASS | SERUM/URINE | 2.0 ML | A/R | NEXT DAY |
| 159 | CHROMOGENIN – A | ELISA | SERUM /PLASMA(CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 160 | CMV IgG | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 161 | CMV IgM | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 162 | COCAINE | ELISA | SERUM/URINE-(CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 163 | CODIN | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 164 | COOMBS TEST (DIRECT) | MICRO | WB EDTA | 2.0 ML | F | SAME DAY |
| 165 | COOMBS TEST(INDIRECT) | MICRO | WB EDTA | 2.0 ML | F | SAME DAY |
| 166 | COPPER | BIOCHEMISTRY | SERUM (AGE+SEX MANDATORY) | 2.0 ML | F | SAME DAY |
| 167 | COPPER (24 HRS Urine) | BIOCHEMISTRY | URINE (AGE+SEX MANDATORY) | 10.0 ML | F | NEXT DAY |
| 168 | CORTISOL FREE ,URINE | CHEMILUMINESCE | URINE-24 HOURS (CLINICAL HISTORY required) MENTION 24 HRS VOLUME | 10.0 ML | F | SAME DAY |
| 169 | CORTISOL(AM) | CHEMILUMINESCE | SERUM AM 7:00-9.00(CLINICAL HISTORY required) | 2.0 ML | F | SAME DAY |
| 170 | CORTISOL( PM) | CHEMILUMINESCE | PM 3:00-5:00(CLINICAL HISTORY required) | 2.0 ML | F | SAME DAY |
| 171 | CPK | BIOCHEMISTRY | SERUM | 2.0 ML | F | SAME DAY |
| 172 | CPK MB | BIOCHEMISTRY | SERUM | 2.0 ML | F | SAME DAY |
| 173 | CPK BB | BIOCHEMISTRY | SERUM | 2.0 ML | F | NEXT DAY |
| 174 | CPK MM | BIOCHEMISTRY | SERUM | 2.0 ML | F | SAME DAY |
| 175 | C-PSA | CHEMILUMINESCE | SERUM(AGE+SEX+CLINICAL HISTORY) | 1.0 ML | F | SAME DAY |
| 176 | CREATININE | BIOCHEMISTRY | SERUM | 2.0 ML | A | SAME DAY |
| 177 | CREATININE CLEARANCE TEST | BIOCHEMISTRY | URINE | 10 ML | F | SAME DAY |
| 178 | CRP (HIGH SENSITIVE) | NEPHELOMETRY | SERUM | 2.0 ML | F | SAME DAY |
| 179 | CRP-QUANTITATIVE | NEPHELOMETRY | SERUM | 2.0 ML | F | SAME DAY |
| 180 | CRYOGLOBULINS QUALITATIVE | INSPECTION,PHYSICAL (HEATING) | SERUM | 2.0 ML | F | NEXT DAY |
| 181 | CRYPTOCOCCUSS ANTIGEN | ELISA | SERUM/CSF | 2.0 ML | F | NEXT DAY |
| 182 | CYCLIC AMP ( URINE) | CHEMILUMINESCE | URINE | 10.0 ML | F | NEXT DAY |
| 183 | CYCLOSPORINE ASSAY | CHEMILUMINESCE | SERUM/WB EDTA | 2.0 ML | A/R | NEXT DAY |
| 184 | CYSTIC FIBROSIS | ELISA | WB EDTA | 2.0 ML | F | NEXT DAY |
| 185 | CYSTICERCOSIS -IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 186 | CYSTICERCOSIS -IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 187 | CYSTINE-C | NEPHELOMETRY | SERUM,FATING 10-12 HOURS (CLINICAL HISTORYREQUIRED) AGE+GENDER IS MANDATORY | 2.0 ML | F | NEXT DAY |
| 188 | D-DIMER | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA | 2.0 ML | F | SAME DAY |
| 189 | DENGUE ANTIGEN NS – 1 | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 190 | DENGUE -IgG | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 191 | DENGUE -IgM | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 192 | DHEA | RIA | SERUM (CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 193 | DHEAS-SO4 | RIA | SERUM (CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 194 | DIAZEPAMINE | TDX | SERUM | 2.0 ML | F | NEXT DAY |
| 195 | DIGOXIN(LANOXIN) | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 196 | DIHYDRO TESTOSTERONE (DHT) | RIA | SERUM | 2.0 ML | F | NEXT DAY |
| 197 | DILENTIN (EPTOIN,PHENYTOIN) | CHEMILUMINESCE | SERUM/PLASMA -EDTA | 2.0 ML | F | SAME DAY |
| 198 | DOPAMINE LEVEL | ELISA | EDTA PLASMA | 2.0 ML | F | NEXT DAY |
| 199 | DRUG OF ABUSE OPIATES,PHENYCYCLIDINE,COCAINE, CANNBINOIDS ,AMPHETAMINE,BARBITURATES, BENZODIAZEPAMINE ,METHODONE,PROPOXYPHEN) | IMMUNOASSAY | URINE +CLINICAL HISTORY | 10.0 ML | F | SAME DAY |
| 200 | DSG1 | ELISA | SERUM | 2.0 ML | A | NEXT DAY |
| 201 | DSG3 | ELISA | SERUM | 2.0 ML | A | NEXT DAY |
| 202 | E B V TITER IgA (VCA) | IMMUNOASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 203 | E B V TITER IgG (VCA) | IMMUNOASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 204 | E B V TITER IgM (VCA) | IMMUNOASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 205 | E2-(ESTRADIOL) | CHEMILUMINESCE | SERUM- (CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 206 | E3(FREE ESTRIOL) | CHEMILUMINESCE | SERUM- (CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 207 | ECHINOCOCUSS – IgG (HYDATID AB) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 208 | ECHINOCOCUSS – IgM (HYDATID AB) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 209 | ECHINOCOCUSS ANTIGEN (HYDATIDAG) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 210 | ECP LEVEL | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 211 | ELECTROLYTES LEVELS URINE | ELECTROLYTE | URINE | 2.0 ML | F | SAME DAY |
| 212 | ELECTROLYTES LEVELS SERUM | ELECTROLYTE | SERUM | 2.0 ML | F | SAME DAY |
| 213 | ELISA- IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 214 | ELISA- IgM | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 215 | ENA ( Extractabel Nucler Antigen) | ELISA | SERUM | 2.0 ML | A | NEXT DAY |
| 216 | ENA Profile-( SSA,SSB,Sm,RNP-Sm,SCL- 70,JO-1) | ELISA | SERUM | 2.0 ML | A | SAME DAY |
| 217 | ENDOMYCIALANTIBODY- IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 218 | ENDOMYCIALANTIBODY- IgG CSF | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 219 | ENDOMYCIALANTIBODY- IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 220 | ENDOMYCIALANTIBODY- IgM CSF | ELISA | CSF | 2.0 ML | F | NEXT DAY |
| 221 | ENTERIC FEVER-IgA | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 222 | EPSTAIN VIRUS -IgG | ELISA | SERUM | 2.0 ML | A | NEXT DAY |
| 223 | EPSTAIN VIRUS -IgM | ELISA | SERUM | 2.0 ML | A | NEXT DAY |
| 224 | ERYTHROCYTE COUNT (ESR) | SEDIMENTATION METHOD | SERUM | 2.0 ML | A | SAME DAY |
| 225 | ERYTHROCYTE COUNT (RBC COUNT) | CELL COUNTER | SERUM | 2.0 ML | A | SAME DAY |
| 226 | ERYTHROPOIETIN- (EPO) | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 227 | ESTROGEN | ELISA | SERUM | 2.0 ML | A | SAME DAY |
| 228 | FACTOR- IX | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA+CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 229 | FACTOR -V | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA+CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 230 | FACTOR- VI | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA+CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 231 | FACTOR-VII | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA+CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 232 | FACTOR- VIII (ANTI HEMOPHILIC GLOBULIN) | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA+CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 233 | FACTOR -X | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA+CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 234 | FACTOR- X II | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA+CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 235 | FACTOR- XI | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA+CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 236 | FERRITINE | CHEMILUMINESCE | SERUM(AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 237 | FIBRINOGEN | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA | 2.0 ML | F | NEXT DAY |
| 238 | FIBRINOGEN DEGRADATION PRODUCT ( FDP ) | COAGULATION | FASTING CITRATED PLATELET POOR PLASMA | 2.0 ML | F | SAME DAY |
| 239 | FILARIA ANTIBODY -IgG | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 240 | FILARIA ANTIBODY -IgM | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 241 | FLUORIDE | ENZYMATIC METHOD | SERUM | 2.0 ML | A | NEXT DAY |
| 242 | FOLIC ACID- (RBC) | CHEMILUMINESCE | SERUM | 2.0 ML | A | SAME DAY |
| 243 | FOLIC ACID?SERUM | CHEMILUMINESCE | SERUM | 2.0 ML | A | SAME DAY |
| 244 | FOTEL HAEMOGLOBULIN | HPLC | SERUM | 2.0 ML | A | NEXT DAY |
| 245 | FREE – T4 | CHEMILUMINESCE | SERUM | 2.0 ML | F | SAME DAY |
| 246 | FREE FATTY ACID | BIOCHEMISTRY | SERUM | 2.0 ML | A | NEXT DAY |
| 247 | FREE -T3 | CHEMILUMINESCE | SERUM | 2.0 ML | F | SAME DAY |
| 248 | FRUCTOSE AMINE LEVEL | BIOCHEMISTRY | SERUM((AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 249 | FSH | CHEMILUMINESCE | SERUM-((AGE+SEX+LMP+CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 250 | G6PD (QUANTITATIVE) | BIOCHEMISTRY | WB EDTA | 2.0 ML | F | SAME DAY |
| 251 | GAD ANTIBODY (GLUTAMIC ACID DECARBOXYLASE) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 252 | GAMA GLUTAMES ALDEHIDE | CHEMILUMINESCE | SERUM | 2.0 ML | A | NEXT DAY |
| 253 | GAMMA G T ESTIMATION | BIOCHEMISTRY | SERUM | 2.0 ML | F | SAME DAY |
| 254 | GARDINAL | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 255 | GASTRIC JUICE DETECTION | RIA | SERUM | 2.0 ML | A | NEXT DAY |
| 256 | GASTRIN LEVEL | RIA | FASTING SERUM CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 257 | GBM ?AB (ANTI GLOMERULAR BASMENT MEMBRANE) | ELISA | SERUM | 2.0 ML | R/F | NEXT DAY |
| 258 | GGPT | CHEMILUMINESCE | SERUM | 2.0 ML | F | SAME DAY |
| 259 | GLUCAGON | RIA | SERUM | 2.0 ML | F | NEXT DAY |
| 260 | GLUCOSE- FASTING | BIOCHEMISTRY | FASTING SERUM | 2.0 ML | A | SAME DAY |
| 261 | GLUCOSE- PP | BIOCHEMISTRY | SERUM | 2.0 ML | A | SAME DAY |
| 262 | GLUCOSE- RANDOM | BIOCHEMISTRY | SERUM | 2.0 ML | A | SAME DAY |
| 263 | GLUTAN ANTIBODY-IgG | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 264 | GLUTAN ANTIBODY-IgM | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 265 | GONADOTROPIN RELEASING HORMONE(GNRH) | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 266 | GONORRHEA – IgM | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 267 | HISTONE ANTIBODY | SERUM | 2.0ML | F | NEXT DAY | |
| 268 | H.PYLORI IgG | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 269 | H.PYLORI -IgM | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 270 | HANTAAN VIRUS-IgG | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 271 | HANTAAN VIRUS-IgG | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 272 | HAPTOGLOBIN | BIOCHEMISTRY | SERUM(AGE+SEX+CLINICAL HISTORY) | 1.0 ML | F | NEXT DAY |
| 273 | HBA1C (GLYCOSYLATED HEAMOGLOBIN) | HPLC | WB EDTA | 2.0 ML | F | SAME DAY |
| 274 | HBA2-(ThalassemiaSicklecell) | HPLC | WB EDTA | 2.0 ML | F | NEXT DAY |
| 275 | HBs ANTIBODY | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 276 | HBDH – (HYDROXYBUTYRATE EHYDROGENASE) | CHEMILUMINESCE | SERUM | 2.0 ML | R | NEXT DAY |
| 277 | HBsANTIGEN (QUANTITATIVE) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 278 | HEAMOGLOBIN | CELL COUNTER | WB-EDTA | 2.0 ML | A | SAME DAY |
| 279 | HEAMOGLOBUNERIA | SPECTROPHOTOMETRY | SERUM | 2.0 ML | A | NEXT DAY |
| 280 | HEAMOSIDRINE | ELISA | URINE | 10.0 ML | R | NEXT DAY |
| 281 | HEP.A VIRUS ANTIBODY – IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 282 | HEP.A VIRUS ANTIBODY – IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 283 | HEP.B-CORE- IgG(Antibody) | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 284 | HEP.B-CORE- IgM(Antibody) | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 285 | HEP.Be ANTIBODY. | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 286 | HEP.Be ANTIGEN | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 287 | HEP.C VIRUS-ANTIBODY | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 288 | HEP.D VIRUS (HDV) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 289 | HEP.E VIRUS – IgG | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 290 | HEP.E VIRUS – IgM | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 291 | HERPES I- IgG | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 292 | HERPES I- IgM | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 293 | HERPES II- IgG | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 294 | HERPES II- IgM | ELISA | SERUM | 2.0 ML | F | SAME DAY |
| 295 | HERPES ZOSTER – IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 296 | HERPES ZOSTER – IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 297 | HGH-HUMAN GROWTH HORMONE | CHEMILUMINESCE | FASTING SERUM | 2.0 ML | F | SAME DAY |
| 298 | HISTAMINE,PLASMA | ELISA | EDTA PLASMA | 2.0 ML | F | NEXT DAY |
| 299 | HIV (QUANTITATIVE) | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 300 | HIV WESTERN BLOTT | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 301 | HLA B 27 | FLOWCYTOMETRY | WB-EDTA+HEPARIN | 2.0 ML | F | NEXT DAY |
| 302 | HOMOCYSTINE | CHEMILUMINESCE | FASTING SERUM/PLASMA-EDTA | 2.0 ML | F | SAME DAY |
| 303 | HOMOCYSTINE ( URINE ) | CHEMILUMINESCE | URINE RANDOM+CLINICAL HISTORY | 10.0 ML | F | SAME DAY |
| 304 | HTLV I and II | IMMUNOASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 305 | HTLV III | IMMUNOASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 306 | HUMAN PEPILOMA VIRUS -IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 307 | HUMAN PEPILOMA VIRUS -IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 308 | HUMAN PLACENTAL LACTOGEN-HPL | ELISA | SERUM/WB EDTA | 2.0 ML | F | NEXT DAY |
| 309 | HE4 | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 310 | IgA CSF (TOTAL) | ELISA | CSF (AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 311 | IgA SERUM (TOTAL) | ELISA | SERUM(AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 312 | IgE | CHEMILUMINESCE | SERUM | 2.0 ML | F | SAME DAY |
| 313 | IGF BP-1 | CHEMILUMINESCE | SERUM | 2.0 ML | F | NEXT DAY |
| 314 | IGF- BP-3 | CHEMILUMINESCE | SERUM(AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 315 | IGF-1 (SOMETOMEDIN- C)-INSULINE LIKE GROTH FACTOR | CHEMILUMINESCE | SERUM(AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 316 | IgG-SERUM | ELISA | SERUM(AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 317 | IgM CSF | ELISA | SERUM(AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | NEXT DAY |
| 318 | IgM Serum | NEPHELOMETRY | SERUM(AGE+SEX+CLINICAL HISTORY) | 2.0 ML | F | SAME DAY |
| 319 | IMMUNOGLOBULINS-IgA | NEPHELOMETRY | SERUM | 2.0 ML | F | SAME DAY |
| 320 | IMMUNOGLOBULINS-IgG | NEPHELOMETRY | SERUM | 2.0 ML | F | SAME DAY |
| 321 | IMMUNOGLOBULINSIgM | NEPHELOMETRY | SERUM | 2.0 ML | F | SAME DAY |
| 322 | INFECTIOUS MONONUCLEOSIS – IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 323 | INFECTIOUS MONONUCLEOSIS – IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 324 | INFLUENZA VIRUS- IgG | ELISA | SERUM | 2.0 ML | A | NEXT DAY |
| 325 | INFLUENZA VIRUS- IgM | ELISA | SERUM | 2.0 ML | A | NEXT DAY |
| 326 | INHIBIN-B | ELISA | SERUM + CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 327 | INHIBIN A (DIMERIC) | ELISA | SERUM + CLINICAL HISTORY | 2.0 ML | F | NEXT DAY |
| 328 | INSULINE – FASTING | CHEMILUMINESCE | FASTING SERUM | 2.0 ML | F | SAME DAY |
| 329 | INSULINE -PP | CHEMILUMINESCE | PP- SERUM | 2.0 ML | F | SAME DAY |
| 330 | INSULINE ANTIBODY | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 331 | INTER ALPHA TRYPSIN INHIBOR | CHEMILUMINESCE | SERUM | 2.0 ML | A | NEXT DAY |
| 332 | INTERPRETATION FOR LUPUS ANTICOAGULANT (LA1,LA2) | FLOWCYTOMRTRY | EDTA | 2.0 ML | F | NEXT DAY |
| 333 | INTRA LUKINE-2 | IMMUNOASSAY | SERUM(AGE+SEX+CLINICAL HISTORY) | 1.0 ML | F | NEXT DAY |
| 334 | INTRA LUKINE-3 | IMMUNOASSAY | SERUM(AGE+SEX+CLINICAL HISTORY) | 1.0 ML | F | NEXT DAY |
| 335 | INTRA LUKINE-4 | IMMUNOASSAY | SERUM(AGE+SEX+CLINICAL HISTORY) | 1.0 ML | F | NEXT DAY |
| 336 | INTRA LUKINE-6 | IMMUNOASSAY | SERUM(AGE+SEX+CLINICAL HISTORY) | 1.0 ML | F | SAME DAY |
| 337 | INTRA LUKINE-I | IMMUNOASSAY | SERUM(AGE+SEX+CLINICAL HISTORY) | 1.0 ML | F | NEXT DAY |
| 338 | INTRINSIC FACTOR ANTIBODY | ELISA | SERUM/WB-EDTA | 2.0 ML | F | NEXT DAY |
| 339 | IODINE LEVEL | SERUM | 2.0 ML | R | NEXT DAY | |
| 340 | IRON | CHEMILUMINESCE | SERUM | 2.0 ML | R | SAME DAY |
| 341 | IRON SATURATION | CHEMILUMINESCE | SERUM | 2.0 ML | R | SAME DAY |
| 342 | IRON STUDY | CHEMILUMINESCE | SERUM | 2.0 ML | F | SAME DAY |
| 343 | ISLET CELL ANTIBODY | IMMUNO FLUORESENT ASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 344 | ISOLEUCINE | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 345 | JAPANESE ENCEPHALITIS -IgG | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 346 | JAPANESE ENCEPHALITIS -IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 347 | JO 1 | IMMUNOASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 348 | KALA-AZAR – IgM | LEISHMANIASIS | SERUM | 2.0 ML | F | NEXT DAY |
| 349 | KALA-AZAR -IgG | LEISHMANIASIS | SERUM | 2.0 ML | F | NEXT DAY |
| 350 | KETONE BODIES | BIOCHEMISTRY | URINE | 10.0 ML | F | NEXT DAY |
| 351 | KOCSAXI IgM | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 352 | KOH EXAMINATION | ELISA | SERUM | 2.0 ML | F | NEXT DAY |
| 353 | L K M ANTIBODY | IMMUNOASSAY | SERUM | 2.0 ML | F | NEXT DAY |
| 354 | LACTATE,PLASMA | BIOCHEMISTRY | PLASMA FLUORIDE | 2.0 ML | F | SAME DAY |
| 355 | SARS-CoV-2 (COVID-19) QUALITATIVE RT-PCR | PCR | Nasopharyangeal + Oropharyngeal Swab | 3 ml | R/F | SAME DAY |